Director, Vancouver Prostate Centre
Chief Executive Officer, PC-TRiADD
Distinguished Professor and Head, Department of Urologic Sciences, UBC
BC Leadership Chair in Prostate Cancer Research
Dr. Gleave is a Distinguished Professor and Chairman of the Department of Urologic Sciences at UBC, and a British Columbia Leadership Chair. He is Co-Founder and Director of the Vancouver Prostate Centre, now a UBC and National Centre of Excellence. He is amongst the top cited and funded scientists in Canada, publishing > 600 papers with >60,000 citations, an H-Index of 122, and attracting >$120M in research funding. Dr.
Associate Director, Development and Supportive Care, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, UBC
Stephen A. Jarislowsky Chair in Urologic Sciences at VGH
Dr. Goldenberg (CM, OBC, MD, FRCSC, FACS, FCAHS) is a urologic surgeon and clinical scientist with an international reputation for excellence in prostate cancer research and treatment. His current research interests involve the evaluation of artificial intelligence algorithms in reading digitized prostate pathology and MRI to risk stratify active surveillance patients, the identification of targeted radioactive Theranostics ligands (aptamers) for diagnosis and treatment of prostate cancer, prostate cancer supportive care and patient education.
Dr. Boniface joined the Prostate Centre in 2008 as COO, after more than 20 years in drug development in both the academic and private industry sectors. Prior to joining our Centre, he was Senior Director of Clinical Research at QLT Inc. where he oversaw the clinical development of the company’s drug platform in Oncology, Urology, Dermatology, and Endocrinology indications. Trials conducted by his team have lead to successful regulatory marketing approvals by the US FDA, Canadian, and European agencies.
Brian Shankaruk has over 25 years experience in the financial field. For 20 years prior to joining the Centre, Brian worked in the insurance and financial services industry, focusing on Canadian and US statutory government reporting. Brian studied accounting at UBC and received his Certified General Accountant designation in 1990. Much of Brian’s recent work has involved systems design and implementation, especially as it relates to operations management and government regulations.
Senior Research Scientist, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
Canada Research Chair in Cancer Therapy Resistance
Dr. Zoubeidi is a Tier 1 Canada Research Chair in Cancer Therapy Resistance. Her research program aims to uncover how standard care of prostate cancer therapy targeting the androgen receptor (AR) induces treatment resistance and controls phenotypic plasticity, which has been associated with the clinically relevant problem of drug resistance in prostate cancer.
Senior Research Scientist, Vancouver Prostate Centre
Head, Precision Cancer Drug Design, Vancouver Prostate Centre
Professor, Dept. of Urologic Sciences, University of British Columbia
Adjunct Professor, Computer Science, Simon Fraser University
Canada Research Chair in Precision Cancer Drug Design
Dr. Artem Cherkasov is a Professor in the Department of Urologic Sciences, Faculty of Medicine at the University of British Columbia, and Senior Scientist at the Vancouver Prostate Centre. His research interests include computer-aided drug discovery (CADD), structure-activity modeling, drug reprofiling, new cancer therapeutics discovery and development of novel CADD tools and applications.
Senior Research Scientist, Vancouver Prostate Centre
Head, Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
Dr Collins is a Senior Research Scientist at the Vancouver Prostate Centre and a Director of The Laboratory for Advanced Genome Analysis (LAGA). In addition, he is an associate adjunct professor at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center and a visiting scientist at Lawrence Berkeley National Laboratory. He has held positions at Lawrence Livermore National Laboratory and Lawrence Berkeley National Laboratory at UCSF.
Senior Research Scientist, Vancouver Prostate Centre
Associate Director, Clinical Research, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia
Khosrowshahi Family Chair
Dr. Black is a surgeon scientist with clinical subspecialty interest in the treatment of urologic cancers, including especially bladder and prostate cancer. He maintains a grant-funded translational research program in urothelial carcinoma with a focus on genomic analysis of response to chemotherapy, mechanisms of resistance to chemotherapy, and novel targeted therapies for bladder cancer. One of his main laboratory projects relates to Notch signaling in bladder cancer.